Extracellular Vesicles and the Application of System Biology and Computational Modeling in Cardiac Repair.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 29976687.
- Also identified by DOI 10.1161/CIRCRESAHA.117.311215 and PMC identifier 6512976.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent literature suggests that extracellular vesicles (EVs), secreted from most cells and containing cell-specific cargo of proteins, lipids, and nucleic acids, are major driver of intracellular communication in normal physiology and pathological conditions. The recent evidence on stem/progenitor cell EVs as potential therapeutic modality mimicking their parental cell function is exciting because EVs could possibly be used as a surrogate for the stem cell-based therapy, and this regimen may overcome certain roadblocks identified with the use of stem/progenitor cell themselves. This review provides a comprehensive update on our understanding on the role of EVs in cardiac repair and emphasizes the applications of stem/progenitor cell-derived EVs as therapeutics and discusses the current challenges associated with the EV therapy.
Medical subject headings
- Cardiovascular Diseases
- Extracellular Vesicles
- Stem Cell Transplantation
- Systems Biology